StockMarketWire.com - JP Morgan Cazenove today downgrades its investment rating on Hikma Pharmaceuticals PLC [LON:HIK] to underweight (from neutral) and raised its price target to 1850p (from 1800p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk